Organovo Holdings Inc. Stock
Price
Target price
€0.93
€0.93
-4.130%
-0.039
-4.130%
-
25.04.24 / Tradegate
WKN: A2QA6Q / Symbol: ONVO / Name: Organovo / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Organovo Holdings Inc. Stock
Organovo Holdings Inc. took a tumble today and lost -€0.039 (-4.130%).
For the coming years our community has positive and negative things to say abot the Organovo Holdings Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Organovo Holdings Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Organovo Holdings Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Organovo Holdings Inc. | -4.130% | -15.818% | -3.037% | -43.742% | -9.747% | -88.013% | -94.745% |
| Chromadex Corp | -0.630% | -11.732% | -9.714% | 152.800% | 135.821% | -48.618% | - |
| Intellia Therapeutics Inc | 1.420% | -6.811% | -24.819% | -43.546% | -35.492% | -71.154% | 22.419% |
| VBI Vaccines Inc. | -3.030% | -0.355% | 7.885% | -78.340% | 5.849% | -99.192% | -98.980% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-25
At first glance, Organovo's financials present a company deep in the investment phase, as indicated by their consistent negative net income and heavy reliance on research and development. Biotechnology is an industry known for its lengthy and capital-intensive path to commercial viability, and Organovo's financials are reflective of these sector-specific challenges.
*Pros: *
*Cons: *
Comments
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONVO provided by MarketBeat
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONVO provided by MarketBeat
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONVO provided by MarketBeat